Scotia Capital’s Eli Lilly LLY Stock Holding History

Scotia Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-100,000	Closed	-$7.36M	–	796
2016 Q4	$7.36M	Buy	+100,000	New	+$7.45M	0.12%	124

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Scotia Capital's LLY Position: Q2 2026 in Review

Scotia Capital increased its Eli Lilly (LLY) stake by 6.8% in Q2 2026, buying an estimated $6.05M and bringing the position to 92,763 shares worth $111M. The position accounts for 0.42% of the portfolio, ranked #46.

Scotia Capital first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Scotia Capital held 92,763 shares of Eli Lilly worth $111M as of Q2 2026.
Scotia Capital bought 5,923 Eli Lilly shares in Q2 2026, an estimated $6.05M.
Eli Lilly made up 0.42% of Scotia Capital's portfolio in Q2 2026, its #46 holding.
Scotia Capital first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.